MeiraGTx repurchases 2.3M shares from Perceptive Master Fund for $18.2M at $7.91 per share

MeiraGTx Holdings plc

Bought 2,300,000 ordinary shares from Perceptive Life Sciences Master Fund at VWAP of $7.91, aggregate $18.2M.
Perceptive Master Fund and affiliates hold >10% of outstanding shares and a $75M note with the company.
Selling shareholder subject to 12-month lock-up on remaining Perceptive shares, with limited exceptions.
Perceptive Credit Holdings III consented to the repurchase under the Notes Purchase Agreement.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

MeiraGTx Holdings plc entered into Share Purchase Agreement with Perceptive Life Sciences Master Fund, Ltd. valued at $18,193,000 (effective 2025-12-31).

Action: entry
Counterparty: Perceptive Life Sciences Master Fund, Ltd.
Value: $18,193,000
Effective: 2025-12-31

Exact text from the filing

On December 31, 2025, MeiraGTx Holdings plc (the “Company”) entered into a share purchase agreement (the “Share Purchase Agreement”) with Perceptive Life Sciences Master Fund, Ltd. (“Perceptive Master Fund”), an affiliate of Perceptive Advisors LLC (“Perceptive Advisors”), pursuant to which the Company agreed to purchase 2,300,000 of the Company’s ordinary shares, $0.00003881 par value per share (the “Ordinary Shares”), from Perceptive Master Fund at a price of $7.91 per share (which was the volume-weighted average price (VWAP) per share on the Nasdaq Global Select Market on December 31, 2025), for an aggregate purchase price of $18,193,000 (the “Share Repurchase”).

View on SEC.gov

295 material agreements filed in the last 30 days. Browse all material agreements →

MeiraGTx Holdings plc filing history →

Source: SEC EDGAR

accession 0001104659-26-000068

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.